Chetan Kamble

• Successful launch of Pulmocare Div. (Respiratory) & Divisional activities starting from product proposal to product launch & marketing activities in limited time
• Currently handling COPD, Asthma, Allergic Rhinitis & Rare Lung disease portfolio (Viloresp, Zadonase & Fibnib)
• Successfully launched Viloresp (Vilanterol + Fluticasone Furoate) an ICS+ Ultra LABA Combination for COPD & Asthma
• Successfully driven the concept of PPF (Progressive Pulmonary Fibrosis) in promotion of Fibnib a brand of Nintedanib.
• Improvement in Market Share & Rank jump in Zadonase (Top 10), FreeAir (6th Rank) & FreeAir-AZ (3rd Rank)
• Leading Healthy Lungs Educator Project with 42 Physical Educators across India with HCPs to shape the future of Pulmonolgy by devising Right diagnosis, Right Management & Right Patient education
• Mentored junior Product Managers, helping them develop essential skills for career growth in the industry

• Handled a portfolio of approx 50 Cr catering to Female Multivitamin & Anti-infective Market (AtoZ Woman & Merosure-O)
• Strategic Launch of Novel Initiative in collaboration with Indian Menopause society to address the issues faced by Women with PMS across Nation
• Secured Leadership Position for AtoZ Woman in terms of prescription in EPO & GLA Market.
• Formulated Strategies to Engage Urologist & Nephrologist across Nation for Merosure-O, a brand of Faropenem
• Launched Lulihalt (Luliconazole) in FY 18-19 & achieved business of 7.5 Cr in Launch Year
• Established the unique differential of Lulihalt (HALT Advantage) in Dermatologist & General practitioners

• Reinforced brand image of SUMO-L with Strategic & operational excellency in FY 17-18 & FY 18-19 & achieved TOP 4 Position in the respective market
• Demonstrated efficiency to work on line extension of SUMO-L i.e. SUMO-L 650 Tabs - growth lever for the portfolio

• Key priority Brands include: Kidicare plus Syrup (Multivitamin), Kidicare-D Syrup (Multivitamin + 1000 IU Vit. D3), Magstone B6 (Potassium magnesium citrate + Vit. B6) & Prulin (Prulifloxacin 600mg).
• Total Portfolio of Rs. 26.0 Cr. (Ref: February'17 AWACS Data)
• Carried out one successful product launch (Kidicare-D Syrup) by creating thrust & proper enthusiasm in the field & registered a Value wise sale of 2.46 Crs in launch year.
• Planning & designing promotional strategies, inputs & ensuring availability of inputs for the field force on scheduled time.

Project:- To check the duration pattern of high dose Atorvastatin (80 mg)
and Storvas (80 mg) in CHD patients in Interventional Cardiologist & Cardiologist

• Ensure proper follow-up with concerned stakeholders i.e. Doctors, Chemists & Stockiest listed in MCL every month, communicate specific product benefits as per strategized brand matrix to generate continuous prescriptions which will help achieve assigned sales targets (Unit wise & Brand wise).
• Part of the core sales team, working in the Gastro, Ortho & CP segment, handling major Brands like PANTOCID Range, RIFAGUT, LACTIHEP & ETOSHINE.
• Successfully launched NUSAM (S-Adenosine Methionine) & was topper in prescription generation
• Achieved major breakthroughs in established Nursing Homes & Corporate Hospitals in Central Mumbai.